AstraZeneca erases billions after sobering reveal
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (3)
- Is Rival ATTR-CM Trial Failure and New AI Deals Altering The Investment Case For Alnylam (ALNY)? Yahoo Finance · 1d ago
- AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable? CNBC · 1d ago
- AstraZeneca erases billions after sobering reveal thestreet.com · 1d ago
Related trends
A new deal on balcony solar just dropped in the US
New legislation in states like New Jersey and New Hampshire is expanding access to 'plug-in' balcony solar systems for renters and homeowners.
Will Oil Prices Soar as the U.S.-Iran Truce Frays? The Answer Lies With China.
Global oil markets face potential volatility as China's oil imports may recover amid fraying U.S.-Iran relations and tensions in the Strait of Hormuz.
Kalshi launches 'Pro' product for users trading multiple markets at same time, perpetual futures
Kalshi is introducing a 'Pro' trading terminal designed for high-activity users and perpetual futures trading.
Netflix Is Down 43% From Its Most Recent High. History Says This May Happen Next
Netflix shares have dropped 43% from their most recent high as the company prepares to release Q2 earnings reports.
Investors alarmed as Asian chipmakers take stranglehold on indices
More Americans are relying on credit cards to buy groceries, new study finds
A new study reveals millions of Americans are turning to credit cards and loans to afford rising grocery costs, leading to increased household debt.